Treatment Outcomes of Unruptured Arteriovenous Malformations With a Subgroup Analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients

医学 动静脉畸形 外科 临床试验 颅内动静脉畸形
作者
John D. Nerva,Alessandra Madia Mantovani,Jason Barber,Louis J. Kim,Jason K. Rockhill,Danial K. Hallam,Basavaraj Ghodke,Laligam N. Sekhar
出处
期刊:Neurosurgery [Lippincott Williams & Wilkins]
卷期号:76 (5): 563-570 被引量:77
标识
DOI:10.1227/neu.0000000000000663
摘要

BACKGROUND: The design and conclusions of A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) trial are controversial, and its structure limits analysis of patients who could potentially benefit from treatment. OBJECTIVE: To analyze the results of a consecutive series of patients with unruptured brain arteriovenous malformations (BAVMs), including a subgroup analysis of ARUBA-eligible patients. METHODS: One hundred five patients with unruptured BAVMs were treated over an 8-year period. From this series, 90 adult patients and a subgroup of 61 patients determined to be ARUBA eligible were retrospectively reviewed. A subgroup analysis for Spetzler-Martin grades I/II, III, and IV/V was performed. The modified Rankin Scale was used to assess functional outcome. RESULTS: Persistent deficits, modified Rankin Scale score deterioration, and impaired functional outcome occurred less frequently in ARUBA-eligible grade I/II patients compared with grade III to V patients combined (P = .04, P = .04, P = .03, respectively). Twenty-two of 39 patients (56%) unruptured grade I and II BAVMs were treated with surgery without and with preoperative embolization, and all had a modified Rankin Scale score of 0 to 1 at the last follow-up. All patients treated with surgery without and with preoperative embolization had radiographic cure at the last follow-up. CONCLUSION: The results of ARUBA-eligible and unruptured grade I/II patients overall show that excellent outcomes can be obtained in this subgroup of patients, especially with surgical management. Functional outcomes for ARUBA-eligible patients were similar to those of patients who were randomized to medical management in ARUBA. On the basis of these data, in appropriately selected patients, we recommend treatment for low-grade BAVMs. ABBREVIATIONS: ARUBA, A Randomized Trial of Unruptured Brain Arteriovenous Malformations BAVM, brain arteriovenous malformation mRS, modified Rankin Scale SAIVMs, Scottish Audit of Intracranial Vascular Malformations
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
makeouthill发布了新的文献求助20
刚刚
思源应助YJ采纳,获得10
刚刚
李健应助CH11采纳,获得10
1秒前
Zxc发布了新的文献求助10
2秒前
小小鱼完成签到,获得积分10
2秒前
清秀的仙人掌完成签到,获得积分10
3秒前
量子星尘发布了新的文献求助10
3秒前
静修者z完成签到,获得积分10
4秒前
善学以致用应助ZZY采纳,获得10
6秒前
科研混子完成签到,获得积分10
6秒前
苹果树下的懒洋洋完成签到 ,获得积分10
6秒前
7秒前
科研通AI5应助DD采纳,获得10
7秒前
七一桉完成签到 ,获得积分10
8秒前
9秒前
胡烨凯完成签到,获得积分10
9秒前
我是老大应助coldspringhao采纳,获得10
10秒前
10秒前
热力学之父完成签到,获得积分10
11秒前
12秒前
13秒前
妮妮完成签到 ,获得积分10
14秒前
量子星尘发布了新的文献求助10
14秒前
科研通AI6应助从容的灯泡采纳,获得30
14秒前
科研通AI5应助冷静的绝音采纳,获得10
14秒前
AoAoo发布了新的文献求助10
15秒前
15秒前
15秒前
16秒前
Lucas应助小城故事和冰雨采纳,获得10
17秒前
领导范儿应助犹豫的寒梅采纳,获得10
17秒前
18秒前
Triumph应助彭宝淦采纳,获得10
19秒前
乐观小之应助科研小白采纳,获得10
19秒前
费勒发布了新的文献求助10
20秒前
20秒前
20秒前
马婷婷发布了新的文献求助10
21秒前
22秒前
坦率的匪应助长生采纳,获得30
22秒前
高分求助中
(禁止应助)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Qualitative Inquiry and Research Design: Choosing Among Five Approaches 5th Edition 2000
International Code of Nomenclature for algae, fungi, and plants (Madrid Code) (Regnum Vegetabile) 1500
Stereoelectronic Effects 1000
Robot-supported joining of reinforcement textiles with one-sided sewing heads 900
Atlas of Quartz Sand Surface Textures 500
SPSS for Windows Step by Step: A Simple Study Guide and Reference, 17.0 Update (10th Edition) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4207207
求助须知:如何正确求助?哪些是违规求助? 3741587
关于积分的说明 11777693
捐赠科研通 3411621
什么是DOI,文献DOI怎么找? 1872239
邀请新用户注册赠送积分活动 927030
科研通“疑难数据库(出版商)”最低求助积分说明 836944